Page last updated: 2024-10-21

pk 11195 and Leukemia, Myeloid, Acute

pk 11195 has been researched along with Leukemia, Myeloid, Acute in 2 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walter, RB1
Pirga, JL1
Cronk, MR1
Mayer, S1
Appelbaum, FR1
Banker, DE1
Ishiguro, K1
Taft, WC1
DeLorenzo, RJ1
Sartorelli, AC1

Other Studies

2 other studies available for pk 11195 and Leukemia, Myeloid, Acute

ArticleYear
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.
    Blood, 2005, Nov-15, Volume: 106, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Bindi

2005
The role of benzodiazepine receptors in the induction of differentiation of HL-60 leukemia cells by benzodiazepines and purines.
    Journal of cellular physiology, 1987, Volume: 131, Issue:2

    Topics: Benzodiazepines; Benzodiazepinones; Cell Differentiation; Cell Line; Humans; Isoquinolines; Leukemia

1987